Human Induced Pluripotent Stem Cell-derived Mesenchymal Stromal Cells therapy (Ruijin Hospital)

N/A

Report date: 2025/07/03 20:00:09

Base Information

Drug NameHuman Induced Pluripotent Stem Cell-derived Mesenchymal Stromal Cells therapy (Ruijin Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsUpdating
Therapy Area/IndicationsGraft vs Host Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesShanghai Rui Jin Hospital
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Rui Jin Hospital
Inactive CompaniesN/A
Active IndicationsGraft vs Host Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A